ONC
Beone Medicines·NASDAQ
--
--(--)
--
--(--)
3.40 / 10
Netural
Fundamental rating is Neutral with a 3.4/10 score. Inventory turnover (1.212) and receivables turnover (6.93) are modest strengths, while PB‑ROE (2.94) is a weakness. Overall, the company shows challenging fundamentals despite decent cash‑up and asset‑MV metrics.
Analysis Checks(9/10)
Total operating revenue (YoY growth rate %)
Value40.23
Score2/3
Weight4.05%
1M Return1.42%
Value40.23
Score2/3
Weight4.05%
1M Return1.42%
Accounts receivable turnover ratio
Value6.93
Score3/3
Weight0.57%
1M Return0.21%
Value6.93
Score3/3
Weight0.57%
1M Return0.21%
Income tax / Total profit (%)
Value31.17
Score2/3
Weight2.57%
1M Return0.80%
Value31.17
Score2/3
Weight2.57%
1M Return0.80%
Interest coverage ratio (EBIT / Interest expense) (%)
Value34.97
Score2/3
Weight-0.81%
1M Return-0.30%
Value34.97
Score2/3
Weight-0.81%
1M Return-0.30%
Cost of sales ratio (%)
Value12.51
Score3/3
Weight3.13%
1M Return1.05%
Value12.51
Score3/3
Weight3.13%
1M Return1.05%
Inventory turnover ratio
Value1.21
Score2/3
Weight-0.73%
1M Return-0.26%
Value1.21
Score2/3
Weight-0.73%
1M Return-0.26%
PB-ROE
Value2.94
Score0/3
Weight13.16%
1M Return4.13%
Value2.94
Score0/3
Weight13.16%
1M Return4.13%
Cash-UP
Value-0.04
Score3/3
Weight31.96%
1M Return7.46%
Value-0.04
Score3/3
Weight31.96%
1M Return7.46%
Operating revenue (YoY growth rate %)
Value40.23
Score2/3
Weight4.39%
1M Return1.53%
Value40.23
Score2/3
Weight4.39%
1M Return1.53%
Asset-MV
Value-0.55
Score2/3
Weight41.70%
1M Return11.96%
Value-0.55
Score2/3
Weight41.70%
1M Return11.96%
Total operating revenue (YoY growth rate %)
Value40.23
Score2/3
Weight4.05%
1M Return1.42%
Value40.23
Score2/3
Weight4.05%
1M Return1.42%
Inventory turnover ratio
Value1.21
Score2/3
Weight-0.73%
1M Return-0.26%
Value1.21
Score2/3
Weight-0.73%
1M Return-0.26%
Accounts receivable turnover ratio
Value6.93
Score3/3
Weight0.57%
1M Return0.21%
Value6.93
Score3/3
Weight0.57%
1M Return0.21%
PB-ROE
Value2.94
Score0/3
Weight13.16%
1M Return4.13%
Value2.94
Score0/3
Weight13.16%
1M Return4.13%
Income tax / Total profit (%)
Value31.17
Score2/3
Weight2.57%
1M Return0.80%
Value31.17
Score2/3
Weight2.57%
1M Return0.80%
Cash-UP
Value-0.04
Score3/3
Weight31.96%
1M Return7.46%
Value-0.04
Score3/3
Weight31.96%
1M Return7.46%
Interest coverage ratio (EBIT / Interest expense) (%)
Value34.97
Score2/3
Weight-0.81%
1M Return-0.30%
Value34.97
Score2/3
Weight-0.81%
1M Return-0.30%
Operating revenue (YoY growth rate %)
Value40.23
Score2/3
Weight4.39%
1M Return1.53%
Value40.23
Score2/3
Weight4.39%
1M Return1.53%
Cost of sales ratio (%)
Value12.51
Score3/3
Weight3.13%
1M Return1.05%
Value12.51
Score3/3
Weight3.13%
1M Return1.05%
Asset-MV
Value-0.55
Score2/3
Weight41.70%
1M Return11.96%
Value-0.55
Score2/3
Weight41.70%
1M Return11.96%
Is ONC undervalued or overvalued?
- ONC scores 3.40/10 on fundamentals and holds a Fair valuation at present. Backed by its 7.46% ROE, 5.37% net margin, 109.84 P/E ratio, 7.23 P/B ratio, and 142.55% earnings growth, these metrics solidify its Netural investment rating.
